Global Personalized Medicines Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI09241615

Publication Date:

September 4, 2024

Pages:

129

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Personalized Medicines market size was valued at US$ 253740 million in 2023. With growing demand in downstream market, the Personalized Medicines is forecast to a readjusted size of US$ 535340 million by 2030 with a CAGR of 11.3% during review period.
The research report highlights the growth potential of the global Personalized Medicines market. Personalized Medicines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Personalized Medicines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Personalized Medicines market.
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Personalized Medicines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Personalized Medicines market. It may include historical data, market segmentation by Type (e.g., PM Diagnostics, PM Therapeutics), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Personalized Medicines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Personalized Medicines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Personalized Medicines industry. This include advancements in Personalized Medicines technology, Personalized Medicines new entrants, Personalized Medicines new investment, and other innovations that are shaping the future of Personalized Medicines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Personalized Medicines market. It includes factors influencing customer ' purchasing decisions, preferences for Personalized Medicines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Personalized Medicines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Personalized Medicines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Personalized Medicines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Personalized Medicines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Personalized Medicines market.
Market Segmentation:
Personalized Medicines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness
Segmentation by application
Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe
Illumina

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Personalized Medicines Market Size 2019-2030
2.1.2 Personalized Medicines Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Personalized Medicines Segment by Type
2.2.1 PM Diagnostics
2.2.2 PM Therapeutics
2.2.3 Personalized Medical Care
2.2.4 Personalized Nutrition & Wellness
2.3 Personalized Medicines Market Size by Type
2.3.1 Personalized Medicines Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Personalized Medicines Market Size Market Share by Type (2019-2024)
2.4 Personalized Medicines Segment by Application
2.4.1 Hospitals Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Dietary Care Centers
2.4.4 Others
2.5 Personalized Medicines Market Size by Application
2.5.1 Personalized Medicines Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Personalized Medicines Market Size Market Share by Application (2019-2024)
3 Personalized Medicines Market Size by Player
3.1 Personalized Medicines Market Size Market Share by Players
3.1.1 Global Personalized Medicines Revenue by Players (2019-2024)
3.1.2 Global Personalized Medicines Revenue Market Share by Players (2019-2024)
3.2 Global Personalized Medicines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Personalized Medicines by Regions
4.1 Personalized Medicines Market Size by Regions (2019-2024)
4.2 Americas Personalized Medicines Market Size Growth (2019-2024)
4.3 APAC Personalized Medicines Market Size Growth (2019-2024)
4.4 Europe Personalized Medicines Market Size Growth (2019-2024)
4.5 Middle East & Africa Personalized Medicines Market Size Growth (2019-2024)
5 Americas
5.1 Americas Personalized Medicines Market Size by Country (2019-2024)
5.2 Americas Personalized Medicines Market Size by Type (2019-2024)
5.3 Americas Personalized Medicines Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Personalized Medicines Market Size by Region (2019-2024)
6.2 APAC Personalized Medicines Market Size by Type (2019-2024)
6.3 APAC Personalized Medicines Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Personalized Medicines by Country (2019-2024)
7.2 Europe Personalized Medicines Market Size by Type (2019-2024)
7.3 Europe Personalized Medicines Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Personalized Medicines by Region (2019-2024)
8.2 Middle East & Africa Personalized Medicines Market Size by Type (2019-2024)
8.3 Middle East & Africa Personalized Medicines Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Personalized Medicines Market Forecast
10.1 Global Personalized Medicines Forecast by Regions (2025-2030)
10.1.1 Global Personalized Medicines Forecast by Regions (2025-2030)
10.1.2 Americas Personalized Medicines Forecast
10.1.3 APAC Personalized Medicines Forecast
10.1.4 Europe Personalized Medicines Forecast
10.1.5 Middle East & Africa Personalized Medicines Forecast
10.2 Americas Personalized Medicines Forecast by Country (2025-2030)
10.2.1 United States Personalized Medicines Market Forecast
10.2.2 Canada Personalized Medicines Market Forecast
10.2.3 Mexico Personalized Medicines Market Forecast
10.2.4 Brazil Personalized Medicines Market Forecast
10.3 APAC Personalized Medicines Forecast by Region (2025-2030)
10.3.1 China Personalized Medicines Market Forecast
10.3.2 Japan Personalized Medicines Market Forecast
10.3.3 Korea Personalized Medicines Market Forecast
10.3.4 Southeast Asia Personalized Medicines Market Forecast
10.3.5 India Personalized Medicines Market Forecast
10.3.6 Australia Personalized Medicines Market Forecast
10.4 Europe Personalized Medicines Forecast by Country (2025-2030)
10.4.1 Germany Personalized Medicines Market Forecast
10.4.2 France Personalized Medicines Market Forecast
10.4.3 UK Personalized Medicines Market Forecast
10.4.4 Italy Personalized Medicines Market Forecast
10.4.5 Russia Personalized Medicines Market Forecast
10.5 Middle East & Africa Personalized Medicines Forecast by Region (2025-2030)
10.5.1 Egypt Personalized Medicines Market Forecast
10.5.2 South Africa Personalized Medicines Market Forecast
10.5.3 Israel Personalized Medicines Market Forecast
10.5.4 Turkey Personalized Medicines Market Forecast
10.5.5 GCC Countries Personalized Medicines Market Forecast
10.6 Global Personalized Medicines Forecast by Type (2025-2030)
10.7 Global Personalized Medicines Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 3G Biotech
11.1.1 3G Biotech Company Information
11.1.2 3G Biotech Personalized Medicines Product Offered
11.1.3 3G Biotech Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 3G Biotech Main Business Overview
11.1.5 3G Biotech Latest Developments
11.2 Quest Diagnostics
11.2.1 Quest Diagnostics Company Information
11.2.2 Quest Diagnostics Personalized Medicines Product Offered
11.2.3 Quest Diagnostics Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Quest Diagnostics Main Business Overview
11.2.5 Quest Diagnostics Latest Developments
11.3 Laboratory Corporation of America
11.3.1 Laboratory Corporation of America Company Information
11.3.2 Laboratory Corporation of America Personalized Medicines Product Offered
11.3.3 Laboratory Corporation of America Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Laboratory Corporation of America Main Business Overview
11.3.5 Laboratory Corporation of America Latest Developments
11.4 Abbott
11.4.1 Abbott Company Information
11.4.2 Abbott Personalized Medicines Product Offered
11.4.3 Abbott Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Abbott Main Business Overview
11.4.5 Abbott Latest Developments
11.5 Agendia NV
11.5.1 Agendia NV Company Information
11.5.2 Agendia NV Personalized Medicines Product Offered
11.5.3 Agendia NV Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Agendia NV Main Business Overview
11.5.5 Agendia NV Latest Developments
11.6 Asuragen Inc
11.6.1 Asuragen Inc Company Information
11.6.2 Asuragen Inc Personalized Medicines Product Offered
11.6.3 Asuragen Inc Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Asuragen Inc Main Business Overview
11.6.5 Asuragen Inc Latest Developments
11.7 Becton Dickinson
11.7.1 Becton Dickinson Company Information
11.7.2 Becton Dickinson Personalized Medicines Product Offered
11.7.3 Becton Dickinson Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Becton Dickinson Main Business Overview
11.7.5 Becton Dickinson Latest Developments
11.8 CardioDx Inc.
11.8.1 CardioDx Inc. Company Information
11.8.2 CardioDx Inc. Personalized Medicines Product Offered
11.8.3 CardioDx Inc. Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 CardioDx Inc. Main Business Overview
11.8.5 CardioDx Inc. Latest Developments
11.9 Foundation Medicine
11.9.1 Foundation Medicine Company Information
11.9.2 Foundation Medicine Personalized Medicines Product Offered
11.9.3 Foundation Medicine Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Foundation Medicine Main Business Overview
11.9.5 Foundation Medicine Latest Developments
11.10 Qiagen
11.10.1 Qiagen Company Information
11.10.2 Qiagen Personalized Medicines Product Offered
11.10.3 Qiagen Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Qiagen Main Business Overview
11.10.5 Qiagen Latest Developments
11.11 Siemens Healthcare
11.11.1 Siemens Healthcare Company Information
11.11.2 Siemens Healthcare Personalized Medicines Product Offered
11.11.3 Siemens Healthcare Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Siemens Healthcare Main Business Overview
11.11.5 Siemens Healthcare Latest Developments
11.12 Amgen
11.12.1 Amgen Company Information
11.12.2 Amgen Personalized Medicines Product Offered
11.12.3 Amgen Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Amgen Main Business Overview
11.12.5 Amgen Latest Developments
11.13 Bristol-Myers Squibb
11.13.1 Bristol-Myers Squibb Company Information
11.13.2 Bristol-Myers Squibb Personalized Medicines Product Offered
11.13.3 Bristol-Myers Squibb Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Bristol-Myers Squibb Main Business Overview
11.13.5 Bristol-Myers Squibb Latest Developments
11.14 GE Healthcare
11.14.1 GE Healthcare Company Information
11.14.2 GE Healthcare Personalized Medicines Product Offered
11.14.3 GE Healthcare Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 GE Healthcare Main Business Overview
11.14.5 GE Healthcare Latest Developments
11.15 Pfizer
11.15.1 Pfizer Company Information
11.15.2 Pfizer Personalized Medicines Product Offered
11.15.3 Pfizer Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Pfizer Main Business Overview
11.15.5 Pfizer Latest Developments
11.16 Sanofi
11.16.1 Sanofi Company Information
11.16.2 Sanofi Personalized Medicines Product Offered
11.16.3 Sanofi Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Sanofi Main Business Overview
11.16.5 Sanofi Latest Developments
11.17 23andMe
11.17.1 23andMe Company Information
11.17.2 23andMe Personalized Medicines Product Offered
11.17.3 23andMe Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 23andMe Main Business Overview
11.17.5 23andMe Latest Developments
11.18 Illumina
11.18.1 Illumina Company Information
11.18.2 Illumina Personalized Medicines Product Offered
11.18.3 Illumina Personalized Medicines Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Illumina Main Business Overview
11.18.5 Illumina Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂